Publications

Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

 20
Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

Tags:

Previous Article

Broadly neutralizing antibodies against emerging delta-coronaviruses

Next Article

Immunotherapy for glioblastoma and its microenvironment

Related Posts

Extracellular vesicle-mediated trafficking of molecular cues during human brain development

Extracellular vesicle-mediated trafficking of molecular...

 21

COLD6-OSM1 module senses chilling for cold tolerance via 20 ,30 -cAMP signaling in rice

COLD6-OSM1 module senses chilling for cold tolerance vi...

 29

Protein N-terminal modifications: molecular machineries and biological implications

Protein N-terminal modifications: molecular machineries...

 51